The effects of reserpine and methylphenidylacetate (ritalin) in mental defectives, spastics, and epileptics.
D000959:Antihypertensive Agents; D004038:Diet, Reducing; D004827:Epilepsy / Q000628:therapy*; D008607:Intellectual Disability / Q000628:therapy*; D008774:Methylphenidate; D009128:Muscle Spasticity; D010880:Piperidines / Q000627:therapeutic use*; D012110:Reserpine; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*; D013035:Spasm / Q000628:therapy*
D000959:Antihypertensive Agents; D010880:Piperidines; D046948:Secologanin Tryptamine Alkaloids; D008774:Methylphenidate; D012110:Reserpine
EPILEPSY/therapy; MENTAL DEFICIENCY/therapy; PIPERIDINES/therapeutic use; RAUWOLFIA ALKALOIDS/therapeutic use; SPASM/therapy